# FDA Inspection 1050153 - Centrient Pharmaceuticals India Private Limited - April 20, 2018

Source: https://www.keypedia.com/records/fda_inspections/centrient-pharmaceuticals-india-private-limited/f5b62930-b685-4f4d-8c7d-e3457aea9e4e
Source feed: FDA_Inspections

> FDA Inspection 1050153 for Centrient Pharmaceuticals India Private Limited on April 20, 2018. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1050153
- Company Name: Centrient Pharmaceuticals India Private Limited
- Inspection Date: 2018-04-20
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1310126 - 2026-01-27](https://www.keypedia.com/records/fda_inspections/centrient-pharmaceuticals-india-private-limited/7060b154-374c-4d34-a8d1-8b909c08e198)
- [FDA Inspection 1175790 - 2022-07-01](https://www.keypedia.com/records/fda_inspections/centrient-pharmaceuticals-india-private-limited/caf5c630-7068-41c3-92f9-449781b7735b)
- [FDA Inspection 954842 - 2015-12-18](https://www.keypedia.com/records/fda_inspections/centrient-pharmaceuticals-india-private-limited/0fb22ae8-2501-41d9-851f-0c19a8dfd6f5)

Company: https://www.keypedia.com/companies/centrient-pharmaceuticals-india-private-limited/cb4cf503-2578-4e8f-b226-d736e975468e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c